Table 1.
Clinical and histological patient characteristics
| Characteristics | n | % |
|---|---|---|
| Age on diagnostic | ||
| <65 | 14 | 38 |
| ≥65 | 23 | 62 |
| Median | 65 (33‐81) | |
| Gender | ||
| Male | 16 | 43 |
| Female | 21 | 57 |
| Smoking status | ||
| Have smoked | 11 | 30 |
| Smoked | 6 | 16 |
| Nonsmoker | 9 | 24 |
| Unknown | 11 | 30 |
| Type of specimen | ||
| Biopsy | 23 | 62 |
| Surgical specimen | 11 | 30 |
| Core‐biopsy | 2 | 5 |
| Cytology | 1 | 3 |
| Site | ||
| Lung | 22 | 59 |
| Lymph node | 7 | 19 |
| Other | 8 | 22 |
| Tumor stage | ||
| T1 | 6 | 16.2 |
| T2 | 4 | 10.8 |
| T4 | 20 | 54.1 |
| Unknown | 7 | 18.9 |
| WHO | ||
| 0‐1 | 24 | 65 |
| 2 | 1 | 3 |
| 3 | 3 | 8 |
| 4 | 2 | 5 |
| Unknown | 7 | 19 |
| Treatment | ||
| Surgery | ||
| Yes | 10 | 27 |
| No | 21 | 57 |
| Unknown | 6 | 16 |
| Radiotherapy | ||
| Yes | 10 | 27 |
| No | 19 | 51 |
| Unknown | 7 | 19 |
| Chemotherapy | ||
| Yes | 25 | 68 |
| No | 5 | 14 |
| Unknown | 7 | 19 |
| Targeted therapy (among ALK/ROS1 pos, n = 27) | ||
| Yes (crizotinib or ceritinb) | 15 | 56 |
| No | 7 | 26 |
| Unknown | 5 | 19 |
Abbreviation: pos, positive. WHO, World Health Organization